Avenue Therapeutics, Inc. (ATXI) has seen some recent volatility in the stock market and its common shares closed at $11.44 yesterday. Traders are starting to take interest of ATXI as the common shares traded as high as $11.81 and as low as $11.30 in the previous market session.

Avenue Therapeutics, Inc. (ATXI) average trading volume is 49.91K. However, in the previous market session Avenue Therapeutics, Inc. (ATXI) exchanged 15,963 shares. The First downside support level on ATXI is $11.14 and the First resistance level on ATXI is $12.01. ATXI fifty day moving average is $10.86 and ATXI 200day moving average is $9.82.

Avenue Therapeutics, Inc. (ATXI) recent performance has been specified by the recent movement in ATXI common shares. ATXI has performed 12.38% over the past 30 days, ATXI has performed 3.34% over the past 3 months and ATXI has shown 87.23% over the past year. Avenue Therapeutics, Inc. (ATXI) has a 1 year range of $4.96 to $12.27. Avenue Therapeutics, Inc. (ATXI) is trading 130.53% from its 1 year low and -6.80% from its 1 year high. Avenue Therapeutics, Inc. (ATXI) is displaying a 2.60% short float displaying the amount short in the float.

ATXI has 16.48M shares outstanding and 6.61M shares in the float. Avenue Therapeutics, Inc. (ATXI) currently has a market cap of $195.05M and income of -10.80M. The EPS next quarter for ATXI is -0.10 and anticipated EPS next year is 123.80%. The market cap of Avenue Therapeutics, Inc. (ATXI) at $195.05M signifies how many Traders own shares of ATXI and is based off the last price ($11.44) of ATXI and the amount of shares outstanding (16.48M) with Avenue Therapeutics, Inc. (ATXI).

Avenue Therapeutics, Inc. (ATXI) has total cash (mrq) of 5.26M, total cash per share (mrq) of 0.31, . Avenue Therapeutics, Inc. (ATXI) operating cash flow (ttm) is -9.2M, ATXI leveraged free cash flow (ttm) is -6.27M.

ATXI is trading 2.26% above (bullish) its SMA20, 7.61% above (bullish) its SMA50 and 22.22% above (bullish) its SMA200.